Aspire Biopharma Holdings, Inc. 10-K filing
Filed 2026-03-30 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001493152-26-013682
- Form type
- 10-K
- CIK
- 0001847345
- Primary document
- https://www.sec.gov/Archives/edgar/data/1847345/000149315226013682/form10-k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aspire Biopharma Holdings, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $6,202 | - | - |
| Cost Of Revenue | $6,318 | - | - |
| Gross Profit | $-116 | - | - |
| Operating Income | $-19.4M | - | - |
| Net Income | $-24.5M | - | - |
| Eps Diluted | -16.38 | - | - |
| Total Assets | $1.3M | - | - |
| Total Liabilities | $7.7M | - | - |
| Shareholders Equity | $-6.4M | - | - |
| Operating Cash Flow | $-4.9M | - | - |